Immune Checkpoint Inhibitor Metastatic NSCLC: Combination Strategies - Episode 2

Biomarker Testing for Targetable Mutations in Non-Small Cell Lung Cancer (NSCLC)

Edward B. Garon, MD, MS, shares his biomarker testing protocols for patients with NSCLC and highlights the most important biomarkers for guiding therapy.